with untreated AML cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of
2014
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
27
References
0
Citations
NaN
KQI